The China hemodialysis and peritoneal dialysis market has experienced significant growth, reaching a valuation of USD 7.18 billion in 2024. This growth is largely driven by the increasing incidence of end-stage renal disease (ESRD) in the country. As the prevalence of chronic kidney diseases rises, the demand for dialysis treatments has surged. With improvements in healthcare infrastructure and...